SYNTHESIS OF A NOVEL DOXORUBICIN-PRODRUG AS A POTENTIAL ANTI-BREAST CANCER AGENT

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SADEGHI ALIABADI H.; DORMIANI K.; JAFARIAN DEHKORDI ABAS

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: PHARMACEUTICAL SCIENCES Year:2004 | Volume:- | Issue:1 Page(s): 61-70

Download Full-Text

Persian Verion

View:

2,088

Download:

Cites:

Information Journal Paper

Title

SYNTHESIS OF A NOVEL DOXORUBICIN-PRODRUG AS A POTENTIAL ANTI-BREAST CANCER AGENT

Author(s)

SADEGHI ALIABADI H. | DORMIANI K. | JAFARIAN DEHKORDI ABAS | Issue Writer Certificate

Keywords

PRODRUGQ3

DOXORUBICINQ3

STEROIDQ3

SYNTHESISQ2

BREAST CANCERQ2

Abstract

Breast cancer is the most important kind of cancer in pre and postmenopausal women. In the treatment of cancers, specially metastatic BREAST CANCER, DOXORUBICIN has the broadest spectrum among of any drugs presently available, but it produces a dose dependent cardiomyopathy and other side effects which limit its clinical usefulness. To overcome this undesired side effect, one solution was to SYNTHESIS DOXORUBICIN based PRODRUGs which can specifically enter into turnor cells, with less distribution in normal tissues. For this purpose estrogen receptors, present in higher amount in cancer cells than normal one, was considered as a target and therefore DOXORUBICIN was linked to estrone as a compound with high affinity to estrogen receptors. In this study, first the 17-keto group of estrone was linked to amine groups on spacer groups such as 4-amino-I-butanol or 5-amino-l-pentanol via schiff s base reaction to prepare an imine functional group that readily reduce to an amine compound. Then resulted amine was reacted with succinic anhydride to yield an acidic derivative of estrone. Isobutylchloro format, afterwards, was used to catalys the final reaction that was an amide bond formation between carboxylic derivative of estrone and amine group located on the danosamine moiety of DOXORUBICIN to yield the final proposed PRODRUG in 43%. Analytical spectrometric methods such as IR, MS and NMR confirmed the successful SYNTHESIS of DOXORUBICIN-estrone PRODRUG which is potentially active against estrogen receptor positive BREAST CANCERs.

Cites

No record.

References

No record.

Cite

APA: Copy

SADEGHI ALIABADI, H., DORMIANI, K., & JAFARIAN DEHKORDI, ABAS. (2004). SYNTHESIS OF A NOVEL DOXORUBICIN-PRODRUG AS A POTENTIAL ANTI-BREAST CANCER AGENT. PHARMACEUTICAL SCIENCES, -(1), 61-70. SID. https://sid.ir/paper/48574/en

Vancouver: Copy

SADEGHI ALIABADI H., DORMIANI K., JAFARIAN DEHKORDI ABAS. SYNTHESIS OF A NOVEL DOXORUBICIN-PRODRUG AS A POTENTIAL ANTI-BREAST CANCER AGENT. PHARMACEUTICAL SCIENCES[Internet]. 2004;-(1):61-70. Available from: https://sid.ir/paper/48574/en

IEEE: Copy

H. SADEGHI ALIABADI, K. DORMIANI, and ABAS JAFARIAN DEHKORDI, “SYNTHESIS OF A NOVEL DOXORUBICIN-PRODRUG AS A POTENTIAL ANTI-BREAST CANCER AGENT,” PHARMACEUTICAL SCIENCES, vol. -, no. 1, pp. 61–70, 2004, [Online]. Available: https://sid.ir/paper/48574/en

Related Journal Papers